A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)

NCT01377480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Chagas Disease

Interventions

DRUG: Posaconazole
DRUG: Placebo for posaconazole
DRUG: Benznidazole

Sponsor

Merck Sharp & Dohme LLC